STRATEC Biomedical AG
Atidarymo kaina
18.06 0.78
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
17.38
Max
18.18
Pajamos | 2.6M -1.7M |
|---|---|
Pardavimai | -22M 53M |
P/E Sektoriaus vid. | 14.63 30.487 |
Pelnas, tenkantis vienai akcijai | -0.357 |
Dividendų pajamingumas | 3.57 |
Pelno marža | -3.206 |
Darbuotojai | 1,343 |
EBITDA | -6.7M 4.1M |
Rekomendacijos | Pirkti |
|---|---|
12 mėnesių prognozė | +57.3% upside |
Dividendų pajamingumas Sektoriaus vid. | 3.57% 3.24% |
|---|---|
Kitas uždarbis | 2026-08-14 |
Rinkos kapitalizacija | -1.9M 212M |
|---|---|
Ankstesnė atidarymo kaina | 17.28 |
Ankstesnė uždarymo kaina | 18.06 |
STRATEC Biomedical AG Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Apie bendrovę STRATEC Biomedical AG
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
